Related Experiment Video

Updated: Aug 12, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

19.3K

Coagulopathy after cardiac surgery may be influenced by a functional plasminogen activator inhibitor polymorphism

Edel Duggan1, Michael J O'Dwyer, Emma Caraher

  • 1Department of Anaesthesia, Trinity Centre for Health Sciences, St. James's Hospital, Dublin, Ireland.

Anesthesia and Analgesia
|May 22, 2007
PubMed

Insights

After cardiac surgery, plasminogen activator inhibitor-1 (PAI-1) gene expression decreases. PAI-1 genotype influences this reduction and the need for blood product transfusions, impacting patient recovery.

Area of Science:

  • Cardiovascular Surgery
  • Molecular Biology
  • Hematology

Background:

  • Cardiac surgery can trigger inflammation and coagulopathy.
  • Investigating plasminogen activator inhibitor-1 (PAI-1) temporal gene expression is crucial.

Purpose of the Study:

  • To examine PAI-1 gene expression patterns post-cardiac surgery.
  • To correlate PAI-1 expression with PAI genotype and perioperative outcomes.

Main Methods:

  • Measured PAI-1 mRNA in mononuclear cells at 1, 6, and 24 hours post-cardiopulmonary bypass (CPB).
  • Analyzed 82 patients undergoing elective cardiac surgery for the 4G/5G PAI-1 polymorphism.

Main Results:

  • PAI-1 gene expression declined in all patients after CPB.
  • Homozygous 5G allele carriers showed greater PAI-1 reduction and higher transfusion rates.
  • No correlation found between PAI-1 expression changes and CPB duration.

Conclusions:

  • PAI-1 gene expression decreases post-CPB.
  • A significant link exists between PAI-1 genotype, gene expression, and transfusion requirements in cardiac surgery patients.
Abstract

More Related Videos

Microfluidics in Assessing Platelet Function06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

1.4K
Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

949

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...